{"id":"sulfalene-pyrimethamine-plus-amodiaquine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL682","moleculeType":"Small molecule","molecularWeight":"355.87"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Sulfalene-pyrimethamine is a combination of sulfadoxine and pyrimethamine, which are sulfonamide and dihydrofolate reductase inhibitors, respectively. Amodiaquine is a 4-aminoquinoline antimalarial that works by interfering with the parasite's heme detoxification pathway. Together, they provide a synergistic effect against the malaria parasite.","oneSentence":"Sulfalene-pyrimethamine plus amodiaquine is an antimalarial combination that works by inhibiting the growth of the malaria parasite.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:41.778Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of uncomplicated malaria"}]},"trialDetails":[{"nctId":"NCT00529620","phase":"PHASE3","title":"Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegal","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2007-09","conditions":"Malaria","enrollment":1833}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dualkin"],"phase":"phase_3","status":"active","brandName":"sulfalene-pyrimethamine plus amodiaquine","genericName":"sulfalene-pyrimethamine plus amodiaquine","companyName":"London School of Hygiene and Tropical Medicine","companyId":"london-school-of-hygiene-and-tropical-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sulfalene-pyrimethamine plus amodiaquine is an antimalarial combination that works by inhibiting the growth of the malaria parasite. Used for Treatment of uncomplicated malaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}